In NDDs like AD, the conversion of the APOE3 allele to APOE4 — the strongest genetic risk factor—in iPSC-derived brain models allowed direct comparisons of their effects on neurons and astrocytes, uncovering functional and transcriptomic differences relevant to disease progression (Lin et al., 2018). The gene discussed is APOE; the disease is Alzheimer disease.